Clinical Trials Logo

Vestibular Migraine clinical trials

View clinical trials related to Vestibular Migraine.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03578354 Withdrawn - Migraine Disorders Clinical Trials

4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

Start date: January 2019
Phase: Phase 2
Study type: Interventional

This phase 2 randomized study will be used to test the efficacy of 4-aminopyridine (4AP) or atenolol to reduce severity and frequency of vestibular and headache symptoms of vestibular migriane sufferers. Blinded study drug will be taken by mouth twice a day for 14 weeks on study.